# Impact of M22 Synergistic Sequential Treatment (SST)

> **NCT02032771** · NA · COMPLETED · sponsor: **Lumenis Be Ltd.** · enrollment: 33 (actual)

## Conditions studied

- Improvement of Wrinkles/Elastosis and/or Pigmentation

## Interventions

- **DEVICE:** M22 IPL and ResurFX

## Key facts

- **NCT ID:** NCT02032771
- **Lead sponsor:** Lumenis Be Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2016-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02032771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02032771, "Impact of M22 Synergistic Sequential Treatment (SST)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02032771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*